Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CP.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.5.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.41NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CR.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BT.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.422NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.56NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.198NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.366NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.441NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.416NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.263NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.135NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.219NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.208NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.125.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.78 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.159NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used